Table 3 Demographic and clinical characteristics of the study population (n = 17,557)
Characteristic | ONS % of total (n) unless otherwise stated | Aurum % of total (n) unless otherwise stated | HES-APC % of total (n) unless otherwise stated |
|---|---|---|---|
Total cohort | 11,295 (100%) | 9,948 (100%) | 10,714 (100%) |
Demographic | |||
Median (IQR) age in years | 77 (10.3) | 77 (13) | 77 (14) |
≥ 65 years | 90.0% (n = 10,176) | 86.2% (n = 8,191) | 85.3% (n = 9,145) |
Male | 63.0% (n = 7,123) | 63.2% (n = 6,011) | 60.7% (n = 6,512) |
Smoking history (ever/current) | 48.9% (n = 5,529) | 66.2%(n = 6,288) | 65.6% (n = 7,030) |
Comorbidities | |||
COPD | 18.2% (n = 2,060) | 19.0% (n = 1,806) | 20.9% (n = 2,240) |
Asthma (in past 2 years) | 6.93% (n = 784) | 10.1% (n = 959) | 10.3% (n = 1,111) |
Lung cancer | 3.0% (n = 348) | 2.1% (n = 206) | 2.8% (n = 305) |
Ischemic stroke | 13.4%(n = 1,513) | 12.0% (n = 1,142) | 13.2% (n = 1,418) |
Heart failure | 17.9% (n = 2,024) | 17.1% (n = 1,629) | 17.6% (n = 1,889) |
Ischemic heart disease | 13.4% (n = 1,523) | 13.6% (n = 1,300) | 13.4% (n = 1,441) |
Myocardial infarction | 13.1% (n = 1,481) | 13.3% (n = 1,267) | 13.2% (n = 1,414) |
Gastroesophageal reflux | 17.8% (n = 2,012) | 17.6% (n = 1,677) | 17.6% (n = 1,892) |